Abbott LaboratoriesABTEarnings & Financial Report
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
ABT Q3 2025 Key Financial Metrics
营收
$11.4B
毛利润
$6.3B
营业利润
$2.1B
净利润
$1.6B
毛利率
55.4%
营业利润率
18.1%
净利率
14.5%
同比增长
6.9%
EPS
$0.94
资金流向
Abbott Laboratories Q3 2025 Financial Summary
Abbott Laboratories reported revenue of $11.4B for Q3 2025, with a net profit of $1.6B (14.5% margin). Cost of goods sold was $5.1B, operating expenses totaled $4.2B.
Key Financial Metrics
| Total Revenue | $11.4B |
|---|---|
| Net Profit | $1.6B |
| Gross Margin | 55.4% |
| Operating Margin | 18.1% |
| Report Period | Q3 2025 |
Abbott Laboratories Annual Revenue by Year
Abbott Laboratories annual revenue history includes year-by-year totals (for example, 2024 revenue was $42.0B).
| Year | Annual Revenue |
|---|---|
| 2024 | $42.0B |
| 2023 | $40.1B |
| 2022 | $43.7B |
利润表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $10.24B | $9.96B | $10.38B | $10.63B | $10.97B | $10.36B | $11.14B | $11.37B |
| 同比增长 | 1.5% | 2.2% | 4.0% | 4.9% | 7.2% | 4.0% | 7.4% | 6.9% |
资产负债表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $73.21B | $72.47B | $73.02B | $74.36B | $81.41B | $81.45B | $84.00B | $84.18B |
| 总负债 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 股东权益 | $38.60B | $38.81B | $39.32B | $39.80B | $47.66B | $48.81B | $50.56B | $50.95B |
现金流量表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $3.04B | $1.02B | $1.96B | $2.71B | $2.87B | $1.42B | $2.05B | $2.79B |
Other Health Care Companies
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B
BDX
Becton Dickinson
营收
$5.3B
净利润
$382.0M
BSX
Boston Scientific
营收
$5.3B
净利润
$670.0M
DXCM
Dexcom
营收
$1.3B
净利润
$267.3M
EW
Edwards Lifesciences
营收
$1.6B
净利润
$291.1M
GEHC
GE HealthCare
营收
$5.7B
净利润
$588.0M
HOLX
Hologic
营收
$1.0B
净利润
$179.1M
IDXX
Idexx Laboratories
营收
$1.1B
净利润
$274.6M
PODD
Insulet Corporation
营收
$783.7M
净利润
$101.6M
ISRG
Intuitive Surgical
营收
$2.9B
净利润
$794.8M